109 related articles for article (PubMed ID: 21156820)
1. Blocking potassium channels: a new principle for treating restenosis?
Olschewski A
Cardiovasc Res; 2011 Feb; 89(2):255-7. PubMed ID: 21156820
[No Abstract] [Full Text] [Related]
2. Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers.
Cheong A; Li J; Sukumar P; Kumar B; Zeng F; Riches K; Munsch C; Wood IC; Porter KE; Beech DJ
Cardiovasc Res; 2011 Feb; 89(2):282-9. PubMed ID: 20884640
[TBL] [Abstract][Full Text] [Related]
3. Characterization of ion channels involved in the proliferative response of femoral artery smooth muscle cells.
Cidad P; Moreno-Domínguez A; Novensá L; Roqué M; Barquín L; Heras M; Pérez-García MT; López-López JR
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1203-11. PubMed ID: 20299686
[TBL] [Abstract][Full Text] [Related]
4. KV1.3: a new therapeutic target to control vascular smooth muscle cell proliferation.
Jackson WF
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1073-4. PubMed ID: 20484702
[No Abstract] [Full Text] [Related]
5. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
6. Kv1.3 blockade inhibits proliferation of vascular smooth muscle cells in vitro and intimal hyperplasia in vivo.
Bobi J; Garabito M; Solanes N; Cidad P; Ramos-Pérez V; Ponce A; Rigol M; Freixa X; Pérez-Martínez C; Pérez de Prado A; Fernández-Vázquez F; Sabaté M; Borrós S; López-López JR; Pérez-García MT; Roqué M
Transl Res; 2020 Oct; 224():40-54. PubMed ID: 32522668
[TBL] [Abstract][Full Text] [Related]
7. K+ channels expression in hypertension after arterial injury, and effect of selective Kv1.3 blockade with PAP-1 on intimal hyperplasia formation.
Cidad P; Novensà L; Garabito M; Batlle M; Dantas AP; Heras M; López-López JR; Pérez-García MT; Roqué M
Cardiovasc Drugs Ther; 2014 Dec; 28(6):501-11. PubMed ID: 25348824
[TBL] [Abstract][Full Text] [Related]
8. A dual-inhibition study on vascular smooth muscle cells with meclofenamic acid and β-irradiation for the prevention of restenosis.
Sauter A; Landers A; Dittmann H; Pritzkow M; Wiesinger B; Bayer M; Bantleon R; Schmehl J; Claussen CD; Kehlbach R
J Vasc Interv Radiol; 2011 May; 22(5):623-9. PubMed ID: 21414804
[TBL] [Abstract][Full Text] [Related]
9. Role of vessel wall and bone marrow syndecan-4 in neointimal hyperplasia: the plot thickens.
Caplice NM
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):952-3. PubMed ID: 21508338
[No Abstract] [Full Text] [Related]
10. Characterization of a new double-injury restenosis model in the rat aorta.
Jahnke T; Karbe U; Schäfer FK; Bolte H; Heuer G; Rector L; Brossmann J; Heller M; Müller-Hülsbeck S
J Endovasc Ther; 2005 Jun; 12(3):318-31. PubMed ID: 15943507
[TBL] [Abstract][Full Text] [Related]
11. Lead contributes to arterial intimal hyperplasia through nuclear factor erythroid 2-related factor-mediated endothelial interleukin 8 synthesis and subsequent invasion of smooth muscle cells.
Zeller I; Knoflach M; Seubert A; Kreutmayer SB; Stelzmüller ME; Wallnoefer E; Blunder S; Frotschnig S; Messner B; Willeit J; Debbage P; Wick G; Kiechl S; Laufer G; Bernhard D
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1733-40. PubMed ID: 20595649
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
[TBL] [Abstract][Full Text] [Related]
13. Aspirin-triggered 15-epi-lipoxin A₄ signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation.
Petri MH; Laguna-Fernandez A; Tseng CN; Hedin U; Perretti M; Bäck M
Int J Cardiol; 2015 Jan; 179():370-2. PubMed ID: 25464488
[No Abstract] [Full Text] [Related]
14. Short-term rapamycin for inhibition of neointima formation after balloon-mediated aortic injury in rats: is there a window of opportunity for systemic prophylaxis of restenosis?
Jahnke T; Schäfer FK; Bolte H; Heuer G; Karbe U; Brossmann J; Brandt M; Heller M; Müller-Hülsbeck S
J Endovasc Ther; 2005 Jun; 12(3):332-42. PubMed ID: 15943508
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.
Köhler R; Wulff H; Eichler I; Kneifel M; Neumann D; Knorr A; Grgic I; Kämpfe D; Si H; Wibawa J; Real R; Borner K; Brakemeier S; Orzechowski HD; Reusch HP; Paul M; Chandy KG; Hoyer J
Circulation; 2003 Sep; 108(9):1119-25. PubMed ID: 12939222
[TBL] [Abstract][Full Text] [Related]
16. Phytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse model.
Shen J; White M; Husband AJ; Hambly BD; Bao S
Eur J Pharmacol; 2006 Oct; 548(1-3):123-8. PubMed ID: 16950243
[TBL] [Abstract][Full Text] [Related]
17. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H
Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949
[TBL] [Abstract][Full Text] [Related]
18. Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway.
Yang YB; Yang YX; Su B; Tang YL; Zhu BY; Hu ZW; Li GY; Li YJ; Liao DF
Eur J Pharmacol; 2007 Sep; 570(1-3):125-34. PubMed ID: 17628533
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
[TBL] [Abstract][Full Text] [Related]
20. Does the effect of microRNAs in vascular neointimal formation depend on cell cycle phase?
Silvestri P; Rigattieri S; Loschiavo P
Circ Res; 2008 May; 102(9):e101; author reply e102. PubMed ID: 18467632
[No Abstract] [Full Text] [Related]
[Next] [New Search]
